Aortic Dissection

Quick Answer

Aortic dissection is a catastrophic vascular emergency caused by an intimal tear allowing blood to dissect along the medial layer, creating a false lumen. Stanford Type A (ascending aorta) requires emergency surgery within 6-12 hours (mortality increases 1-2% per hour delay). Type B (descending aorta) is managed medically unless complicated by malperfusion, rupture, or refractory pain.

Immediate ICU Management:

1. Beta-blockade FIRST: Esmolol or labetalol to target HR below 60 bpm (reduces dP/dt)
2. Blood pressure control: Target SBP 100-120 mmHg (add vasodilator AFTER beta-blockade)
3. Analgesia: IV morphine or fentanyl (reduces sympathetic surge)
4. Definitive imaging: CTA chest/abdomen/pelvis (98% sensitivity)
5. Emergency cardiothoracic surgery consultation for Type A

Classic triad: Sudden-onset tearing chest/back pain (90%), pulse deficit (15-30%), aortic regurgitation (40-75% in Type A).

---

CICM Exam Focus

High-Yield Topics for Second Part Written/Viva

Must-know classifications:

• Stanford: Type A (ascending, surgical) vs Type B (descending, medical)
• DeBakey: Type I (ascending + arch/descending), Type II (ascending only), Type III (descending only)

Anti-impulse therapy (first-line ICU management):

• Beta-blockade reduces dP/dt (rate of rise of LV pressure) → limits dissection propagation
• Why beta-blocker first: Prevents reflex tachycardia from vasodilators
• Target: HR below 60 bpm, SBP 100-120 mmHg

Type A surgical indications (all are absolute):

• Any involvement of ascending aorta
• Complications: AR, tamponade, coronary involvement, stroke

Type B complicated criteria (require TEVAR or surgery):

• Malperfusion syndrome (mesenteric, renal, limb)
• Rupture or impending rupture
• Refractory hypertension despite maximal medical therapy
• Refractory pain
• Aortic expansion greater than 5 mm in 6 months

Malperfusion syndromes (40-60% mortality):

• Mechanism: False lumen compresses true lumen → end-organ ischemia
• Mesenteric: Highest mortality, requires urgent fenestration/stenting
• Coronary: RCA involvement in 10-15% of Type A (presents as inferior STEMI)
• Cerebral: Stroke in 5-10%, usually embolic or hypoperfusion
• Renal: AKI in 15-20%, worsens prognosis
• Limb: Pulse deficit in 15-30%

Diagnostic pearls:

• D-dimer greater than 500 ng/mL has 97% sensitivity (excellent rule-out)
• CTA: 98% sensitivity, rapid, shows extent and complications
• TEE: 98% sensitivity, 95% specificity, best for intraoperative/unstable patients
• TTE: Poor sensitivity (60-70%), misses 30-40% of dissections

Viva scenarios:

1. 65M with sudden tearing interscapular pain, BP 180/110, HR 95 → Discuss immediate management
2. Type A with tamponade → How to diagnose, manage pre-operatively
3. Type B with abdominal pain and rising lactate → Recognize mesenteric malperfusion
4. Post-op Type A repair with new neurological deficit → Differential diagnosis

---

Key Points

Epidemiology

• Incidence: 3-6 cases per 100,000 person-years (PMID: 10679685)
• Age: Mean 63 years (Type A ~61 years, Type B ~64 years)
• Gender: Male predominance 65-70%
• Risk factors: Hypertension (70-80%), pre-existing aneurysm (13-20%), connective tissue disease (Marfan 5%, Ehlers-Danlos, Loeys-Dietz), bicuspid aortic valve, cocaine use

Pathophysiology

• Intimal tear → blood enters media → longitudinal dissection creating false lumen
• Entry tear locations: Ascending aorta (65%), descending aorta just distal to left subclavian (20%), aortic arch (10%)
• Propagation: Antegrade (90%) or retrograde (10%), driven by pulse pressure and dP/dt
• Complications:
  • "Aortic regurgitation (40-75% Type A): Annular dilatation, cusp prolapse, dissection flap interference"
  • "Tamponade (15-20% Type A): Rupture into pericardium"
  • "Coronary malperfusion (10-15% Type A): RCA > LCA, presents as MI"
  • "Stroke (5-10%): Carotid involvement or hypoperfusion"
  • "Visceral malperfusion (15-30%): Mesenteric (5-8%), renal (15-20%)"

Classification Systems

Stanford Classification (clinical management-based):

• Type A: Involves ascending aorta (regardless of tear origin) → Emergency surgery
• Type B: Descending aorta only (distal to left subclavian) → Medical management (unless complicated)

DeBakey Classification (anatomical):

• Type I: Originates in ascending, extends to arch/descending (60%)
• Type II: Confined to ascending aorta (10-15%)
• Type III: Originates in descending aorta (20-25%)
  • "IIIa: Thoracic aorta only"
  • "IIIb: Extends below diaphragm"

Clinical Presentation

Pain characteristics (IRAD registry):

• Sudden onset: 90% (maximal intensity immediately) (PMID: 10671550)
• Quality: Sharp (64%), tearing/ripping (50%) (PMID: 29037306)
• Location:
  • "Type A: Anterior chest pain (71%)"
  • "Type B: Back/interscapular pain (64%), abdominal pain (43%)"
• Migratory pain: 15-30% (pain "moves" as dissection propagates) (PMID: 25661557)
• Painless dissection: 6-10% (more common in elderly, Marfan syndrome) (PMID: 22215201)

Physical examination findings:

• Pulse deficit: 15-30% (any peripheral pulse asymmetry or absence)
• Blood pressure differential: greater than 20 mmHg between arms (suggests subclavian involvement)
• Aortic regurgitation murmur: 40-75% in Type A (early diastolic, high-pitched)
• Hypotension/shock: Tamponade, rupture, or severe AR
• Neurological deficits: Stroke (5-10%), spinal cord ischemia (rare)
• Horner syndrome: Compression of superior cervical sympathetic ganglion

Atypical presentations:

• Syncope (10-15%): Tamponade, arrhythmia, cerebral hypoperfusion
• Acute limb ischemia: Iliac/femoral involvement
• Acute abdomen: Mesenteric ischemia
• Acute heart failure: Severe AR
• STEMI equivalent: Coronary ostial involvement

---

Diagnosis

Clinical Suspicion (High-Risk Features)

Predisposing conditions:

• Hypertension (uncontrolled)
• Known aortic aneurysm
• Connective tissue disorders (Marfan, Ehlers-Danlos vEDS, Loeys-Dietz)
• Bicuspid aortic valve
• Recent cardiac surgery or catheterization (iatrogenic)
• Cocaine/stimulant use
• Pregnancy/peripartum (especially with coarctation)

Pain features:

• Abrupt onset (maximal at onset, not crescendo)
• Severe (often described as "worst pain of life")
• Tearing/ripping quality
• Anterior chest (Type A) or interscapular (Type B)

High-risk exam findings:

• Pulse deficit or blood pressure differential
• Focal neurological deficit
• New aortic regurgitation murmur
• Hypotension with elevated JVP (tamponade)

Biomarkers

D-dimer (IRAD-Bio study, PMID: 19131376):

• Sensitivity: 97% (excellent rule-out if below 500 ng/mL)
• Specificity: Low (~50-60%), elevated in PE, MI, sepsis, trauma
• Negative predictive value: 96-98%
• Limitations: Cannot exclude dissection in isolation; must combine with imaging

Smooth muscle myosin heavy chain (SMMHC):

• Sensitivity: 90.9% in first 3 hours (PMID: 10636261)
• Specificity: 95.7% (superior to D-dimer)
• Peak time: 3-6 hours after symptom onset
• Limitation: Not widely available

Imaging Modalities

CT Angiography (CTA) - First-line in stable patients:

• Sensitivity: 94-98% (PMID: 16618952, 29845016)
• Specificity: 94-99%
• Protocol: CTA chest/abdomen/pelvis (evaluate entire aorta + branches)
• Findings:
  • "Intimal flap: Linear filling defect separating true and false lumens"
  • "False lumen: Often larger, delayed contrast opacification, external compression"
  • "Complications: Pericardial effusion, pleural effusion, periaortic hematoma, branch vessel involvement"
• Advantages: Rapid, widely available, visualizes entire aorta and complications
• Disadvantages: Contrast nephropathy, radiation, requires patient transport

Transesophageal Echocardiography (TEE):

• Sensitivity: 98% (PMID: 16618952)
• Specificity: 95%
• Best for:
  • Unstable patients (can be done at bedside or in OR)
  • Intraoperative assessment
  • Evaluating AR, coronary ostia, pericardial effusion
  • When CTA contraindicated (contrast allergy, renal failure)
• Limitations: Blind spot at distal ascending aorta/proximal arch (tracheal air artifact), operator-dependent, semi-invasive

Transthoracic Echocardiography (TTE):

• Sensitivity: 60-70% (poor, misses 30-40%)
• Role: Limited; useful for detecting AR, pericardial effusion, regional wall motion abnormalities (coronary involvement)
• Not adequate to rule out dissection

MR Angiography (MRA):

• Sensitivity: 98%
• Specificity: 98% (highest among all modalities) (PMID: 16618952)
• Advantages: No radiation, no contrast (can use non-contrast techniques), excellent anatomical detail
• Disadvantages: Time-consuming (30-45 min), not suitable for unstable patients, limited availability, contraindications (pacemakers, metallic implants)
• Role: Follow-up imaging, chronic dissection surveillance, young patients (radiation avoidance)

Aortic angiography (historical gold standard, rarely used now):

• Invasive, time-consuming, misses thrombosed false lumen
• Replaced by CTA/MRA

Diagnostic Algorithms

ADD Risk Score (Aortic Dissection Detection):

• 1 point each for:
  • High-risk Predisposing condition (Marfan, recent aortic manipulation)
  • High-risk Pain features (abrupt onset, tearing quality)
  • High-risk Exam findings (pulse deficit, BP differential, neurological deficit, new AR)
• Score ≥1: Further imaging warranted
• Score 0 + D-dimer below 500 ng/mL: Can rule out dissection

ICU approach:

1. High clinical suspicion → CTA chest/abdomen/pelvis (first-line)
2. Unstable patient → Bedside TEE (if available) or urgent CTA with resuscitation
3. Contraindication to CTA → TEE or MRA
4. Negative imaging but high suspicion persists → Second imaging modality (TEE or MRA)

---

Intensive Care Management

Initial Resuscitation and Stabilization

Immediate priorities (ABCDE approach):

1. Airway/Breathing: High-flow O₂, prepare for intubation if needed
2. Circulation: Establish large-bore IV access (avoid femoral if dissection extends to iliacs)
3. Monitoring:
   • Continuous ECG, SpO₂
   • Arterial line (right radial preferred, avoid affected limb if pulse deficit)
   • Central venous access (if needed for pressors, volume monitoring)
   • Four-limb BP (document pulse deficits, choose highest BP arm for monitoring)
4. Analgesia: IV morphine 2-5 mg or fentanyl 25-50 mcg (titrate to pain relief)
5. Definitive imaging: Arrange urgent CTA or TEE

Anti-Impulse Therapy (Hemodynamic Control)

CRITICAL PRINCIPLE: Beta-blockade BEFORE vasodilators to prevent reflex tachycardia

Step 1: Beta-Blocker (FIRST-LINE) (PMID: 36322954, 32535738):

Esmolol (preferred in ICU for titratability):

• Mechanism: Ultra-short-acting β₁-selective antagonist (half-life 9 minutes)
• Dosing:
  • "Loading: 500 mcg/kg IV over 1 minute"
  • "Infusion: 50-300 mcg/kg/min (titrate to effect)"
• Target: HR below 60 bpm
• Advantages: Rapid onset/offset, easily titratable, safe in uncertain hemodynamics
• PMID: 2884277

Labetalol (combined α + β blockade):

• Mechanism: Non-selective β-blocker + α₁-antagonist (ratio 1:7)
• Dosing:
  • "Bolus: 10-20 mg IV over 2 min, repeat 40-80 mg q10min (max 300 mg)"
  • "Infusion: 0.5-2 mg/min"
• Target: HR below 60 bpm, SBP 100-120 mmHg
• Advantages: Dual HR and BP control, useful in severe hypertension
• Disadvantages: Long half-life (3-6 hours), difficult to reverse
• PMID: 10910626

Metoprolol (alternative for stable patients):

• Bolus: 5 mg IV q5min (max 15 mg)
• Transition to oral: 25-50 mg PO q6-12h

Contraindications to beta-blockers:

• Severe bradycardia (HR below 50 bpm)
• High-degree AV block
• Decompensated heart failure
• Active bronchospasm (relative)
• Alternative: Diltiazem 10-20 mg IV, then 5-15 mg/h infusion

Step 2: Vasodilator (AFTER Beta-Blockade) (PMID: 36322954):

Sodium nitroprusside:

• Dosing: 0.3-10 mcg/kg/min IV infusion
• Target: SBP 100-120 mmHg
• Monitoring: Arterial line essential for continuous BP monitoring
• Toxicity: Cyanide/thiocyanate (limit to 24-48h, check levels if prolonged use)
• Advantages: Rapid onset, easily titratable, potent

Nicardipine (alternative):

• Dosing: 5 mg/h IV, titrate by 2.5 mg/h q5-15min (max 15 mg/h)
• Advantages: No cyanide toxicity, longer duration
• PMID: 17616606

Clevidipine (ultra-short-acting):

• Dosing: 1-2 mg/h, double q90sec to target (max 32 mg/h)
• Advantages: Fastest titration, minimal tachycardia

Step 3: Analgesia (PMID: 36194405, 31362804):

Morphine:

• Dosing: 2-5 mg IV q5-10min, then infusion 1-5 mg/h
• Advantages: Vasodilation (mild), reduces sympathetic surge
• Disadvantages: Histamine release, nausea/vomiting

Fentanyl:

• Dosing: 25-50 mcg IV q5-10min, then infusion 25-100 mcg/h
• Advantages: Hemodynamically stable, rapid onset, no histamine release
• Disadvantages: Short duration, requires frequent redosing

Hemodynamic targets (ACC/AHA 2022):

• Heart rate: below 60 bpm (reduces dP/dt)
• Systolic BP: 100-120 mmHg (mean arterial pressure 60-75 mmHg)
• Pain: 0-2/10 (inadequate analgesia drives hypertension)

Intubation and Mechanical Ventilation (PMID: 30005315, 28131349)

Indications:

• Respiratory failure
• Airway protection (decreased GCS)
• Facilitation of emergency surgery
• Refractory hypertension (need for deep sedation)

High-risk procedure (laryngoscopy triggers sympathetic surge):

Pre-intubation optimization:

1. Hemodynamic blunting: Esmolol 1-2 mg/kg IV bolus OR fentanyl 3-5 mcg/kg
2. Vasodilator ready: Nicardipine or nitroprusside infusion primed
3. Targets: HR below 60 bpm, SBP below 140 mmHg BEFORE laryngoscopy

Induction agents:

• Propofol: 1-2 mg/kg IV (reduces SVR, blunts response)
• Ketamine: AVOID (increases BP and HR)
• Etomidate: Hemodynamically neutral (alternative if hypotensive)

Neuromuscular blockade:

• Rocuronium: 1-1.2 mg/kg IV (rapid sequence)

Post-intubation sedation (PMID: 28131349):

• Propofol: 25-75 mcg/kg/min (reduces SVR, easy titration)
• Dexmedetomidine: 0.2-0.7 mcg/kg/h (reduces sympathetic tone, no respiratory depression)
• Fentanyl: 25-100 mcg/h (analgesia)

Ventilator settings:

• Mode: Volume control or pressure control
• Tidal volume: 6-8 mL/kg IBW (lung-protective)
• PEEP: 5-8 cmH₂O (avoid excessive PEEP → impairs venous return)
• Avoid hypercapnia: PaCO₂ 35-40 mmHg (hypercapnia increases sympathetic tone)

Management of Complications

Cardiac tamponade (15-20% of Type A):

Diagnosis:

• Beck's triad: Hypotension, elevated JVP, muffled heart sounds
• Pulsus paradoxus greater than 10 mmHg
• ECG: Low voltage, electrical alternans
• TEE/TTE: Pericardial effusion with RA/RV diastolic collapse

Management:

• DO NOT perform pericardiocentesis (may precipitate exsanguination by relieving tamponade)
• Permissive hypotension acceptable (tamponade provides hemostasis)
• Urgent cardiothoracic surgery (definitive treatment)
• Temporizing: Volume resuscitation (increases preload), minimize sedation

Acute aortic regurgitation (40-75% of Type A):

Mechanism:

• Annular dilatation
• Dissection flap prolapsing into LVOT
• Commissural detachment

Diagnosis:

• Early diastolic murmur (may be soft if rapid equalization)
• Wide pulse pressure (may be absent in acute AR)
• TEE: Regurgitant jet, premature MV closure

Management:

• Avoid bradycardia (shortens diastole, worsens regurgitation)
• Afterload reduction: Nitroprusside (reduces regurgitant volume)
• Urgent surgery: Only definitive treatment

Coronary malperfusion (10-15% of Type A):

Mechanism:

• False lumen compressing coronary ostium (RCA > LCA)
• Dissection flap extending into coronary artery

Presentation:

• Inferior STEMI (RCA involvement): ST elevation II, III, aVF
• Anterior STEMI (LCA involvement, rare): ST elevation V1-V6
• Cardiogenic shock

Diagnosis:

• ECG: STEMI pattern
• TEE: Regional wall motion abnormality
• CTA: Coronary ostial involvement (if time permits)

Management:

• DO NOT give thrombolytics (catastrophic in dissection)
• DO NOT perform PCI (coronary intervention futile if dissection involves ostium)
• Urgent surgery: Aortic root repair ± CABG

Stroke/neurological deficit (5-10%):

Mechanisms:

• Carotid artery involvement (malperfusion)
• Embolization from false lumen thrombus
• Hypoperfusion (tamponade, shock)

Management:

• DO NOT give thrombolytics (even if presenting as stroke)
• Imaging: CTA head/neck to assess carotid involvement
• Surgery: Emergent repair (may restore cerebral perfusion)
• Prognosis poor if stroke present pre-operatively

Mesenteric ischemia (5-8%, highest mortality):

Diagnosis:

• Abdominal pain out of proportion to exam
• Rising lactate (greater than 2 mmol/L)
• Metabolic acidosis
• CTA: Bowel wall thickening, pneumatosis, SMA/celiac involvement

Management (PMID: 20005713, 32014661, 24787053):

• Urgent endovascular fenestration (percutaneous balloon fenestration of dissection flap to restore true lumen flow)
• OR hybrid approach: Central aortic repair + mesenteric revascularization
• Mortality: 40-60% even with intervention

Renal malperfusion (15-20%):

Diagnosis:

• Acute kidney injury (Cr rising)
• Oliguria/anuria
• CTA: Renal artery involvement, delayed nephrogram

Management:

• Optimize hemodynamics (MAP greater than 65 mmHg)
• Avoid nephrotoxins
• Endovascular fenestration if persistent ischemia
• Prepare for renal replacement therapy

Limb ischemia (15-30%):

Diagnosis:

• Pulse deficit (absent radial, femoral, popliteal, pedal pulses)
• Cool, pale, pulseless limb
• Pain, paresthesias, paralysis (late findings)

Management:

• Document all pulses (will guide surgical approach)
• Endovascular fenestration or extra-anatomic bypass
• Monitor for compartment syndrome post-revascularization

---

Definitive Management

Type A Dissection (Stanford A, DeBakey I & II)

Absolute indication for emergency surgery (any ascending aorta involvement):

Surgical approach:

• Median sternotomy
• Cardiopulmonary bypass ± deep hypothermic circulatory arrest (DHCA)
• Ascending aorta replacement (Dacron tube graft)
• Aortic root repair (if involved):
  • Valve-sparing (David/Yacoub procedure)
  • Bentall procedure (composite valve + root replacement)
• Arch repair (if involved): Hemiarch or total arch replacement
• Coronary reimplantation (if root replaced)

Timing (PMID: 25673648):

• Mortality increases 1-2% per hour of delay
• Target: Surgery within 6-12 hours of diagnosis
• Only delays acceptable: Transfer to cardiac surgery center, patient optimization (very brief)

Surgical mortality:

• Operative mortality: 10-20% (high-volume centers)
• Risk factors: Age greater than 70, tamponade, shock, preoperative stroke, malperfusion syndrome

Post-operative ICU care (PMID: 32684120):

• Neurological monitoring: Early sedation weaning to assess for stroke (5-10% post-op)
• Hemodynamic targets: SBP 100-120 mmHg, HR below 80 bpm
• Coagulation management: Bleeding common (CPB, DHCA), transfuse to Hb greater than 80 g/L, platelets greater than 50×10⁹/L
• Acute kidney injury: 20-30% post-op, may require RRT
• Delayed complications: Recurrent dissection, aneurysm formation in distal aorta

Type B Dissection (Stanford B, DeBakey III)

Uncomplicated Type B → Medical management:

Criteria for "uncomplicated":

• No malperfusion syndromes
• No rupture or impending rupture (periaortic hematoma)
• Hemodynamically stable
• Pain controlled on medical therapy
• No rapid aortic expansion

Medical therapy:

• Anti-impulse therapy: Beta-blocker + vasodilator (as above)
• Target BP: SBP 100-120 mmHg (strict control)
• Target HR: below 60 bpm
• Pain control: Opioids
• Monitor in ICU: 24-48h minimum

Outcomes:

• 30-day mortality: 10-15% (medical management)
• 1-year mortality: 20-30%

Complicated Type B → Thoracic Endovascular Aortic Repair (TEVAR) or open surgery:

Indications for intervention:

1. Malperfusion syndrome: Visceral, renal, limb ischemia
2. Rupture or impending rupture: Hemothorax, periaortic hematoma, rapidly enlarging effusion
3. Refractory hypertension: Despite maximal medical therapy
4. Refractory pain: Uncontrolled despite analgesia (suggests ongoing propagation)
5. Rapid aortic expansion: greater than 5 mm in 6 months or greater than 1 cm in 1 year

TEVAR approach:

• Percutaneous femoral access (requires adequate iliac/femoral arteries)
• Stent-graft deployment covering entry tear (proximal descending aorta)
• Goal: Seal entry tear → thrombose false lumen → promote aortic remodeling

INSTEAD-XL trial (PMID: 24029429):

• Population: Uncomplicated chronic Type B dissection (greater than 14 days)
• Comparison: TEVAR + optimal medical therapy (OMT) vs OMT alone
• 5-year outcomes:
  • "Aorta-specific mortality: 6.9% (TEVAR) vs 19.3% (OMT), p=0.04"
  • "Disease progression: 27.0% (TEVAR) vs 46.1% (OMT), p=0.04"
  • "Aortic remodeling: 91.3% (TEVAR) vs 19.4% (OMT)"
• Conclusion: TEVAR reduces late aortic events and mortality compared to medical therapy alone in subacute/chronic uncomplicated Type B

TEVAR complications:

• Stroke (2-5%): Arch manipulation
• Spinal cord ischemia (2-5%): Coverage of intercostal/spinal arteries
• Endoleak (10-20%): Persistent false lumen perfusion
• Retrograde Type A dissection (1-2%): Proximal stent-graft extension
• Access vessel injury (5-10%): Iliac/femoral rupture

Open surgical repair (rarely needed):

• Reserved for TEVAR failure or unsuitable anatomy
• Left thoracotomy, descending aorta replacement
• High morbidity/mortality (20-30%)

---

Prognosis and Long-Term Follow-Up

Natural History (PMID: 10679685, 23948514, 17409354)

Untreated Type A:

• 24-hour mortality: 25%
• 48-hour mortality: 50%
• 1-week mortality: 75%
• Death from: Rupture (pericardial, pleural), tamponade, acute AR, MI

Treated Type A (surgical):

• Operative mortality: 10-20%
• 5-year survival: 70-90%
• 10-year survival: 50-70%

Untreated Type B:

• 30-day mortality: 10-15%
• 1-year mortality: 20-30%

Treated Type B (medical):

• 30-day mortality: 10-15%
• 5-year survival: 60-80%

Predictors of Mortality

Pre-operative risk factors:

• Age greater than 70 years
• Shock or hypotension (SBP below 90 mmHg)
• Cardiac tamponade
• Preoperative stroke or coma
• Malperfusion syndrome (especially mesenteric)
• Renal failure
• Prior cardiac surgery

False lumen status (PMID: 17652650, 28315187, 18519129):

• Complete thrombosis: Best prognosis (lowest expansion, lowest mortality)
• Patent false lumen: Moderate risk (25-40% require intervention within 5 years)
• Partial thrombosis: Highest risk (2.7-fold mortality increase, rapid expansion)

Surveillance Imaging (PMID: 36322395, 25173338, 31174419)

Post-discharge imaging protocol (ACC/AHA 2022):

Imaging modality choice:

• CTA: First-line for most patients (rapid, widely available)
• MRA: Young patients (radiation avoidance), contrast allergy, renal impairment
• Alternate CTA/MRA: Reduce lifetime radiation exposure

Triggers for intervention during surveillance:

• Aortic diameter:
  • "Ascending: greater than 55 mm (greater than 50 mm if Marfan/bicuspid aortic valve)"
  • "Descending: greater than 60 mm"
• Growth rate:
  • greater than 5 mm in 6 months
  • greater than 10 mm in 1 year
• New symptoms: Pain, hoarseness, dysphagia (compression)
• Complications: New AR, new malperfusion

Long-Term Medical Therapy

Beta-blocker therapy (lifelong):

• First-line: Metoprolol 50-100 mg PO BID, atenolol 50-100 mg PO daily, or bisoprolol 5-10 mg PO daily
• Target: HR below 60 bpm, SBP below 120 mmHg

ACE inhibitor/ARB (especially if Marfan syndrome):

• Losartan: 50-100 mg PO daily (PMID: 25176143 - reduces aortic root growth in Marfan)
• Alternative: Enalapril, lisinopril

Blood pressure targets:

• SBP below 120 mmHg (strict control to prevent propagation/aneurysm expansion)
• Home BP monitoring recommended

Statins (if atherosclerotic disease):

• Atorvastatin 40-80 mg PO daily

Lifestyle modifications:

• Avoid isometric exercise (weightlifting, pushing/pulling heavy objects)
• Avoid Valsalva maneuvers
• Aerobic exercise permitted (walking, swimming, cycling at low intensity)
• No contact sports

Genetic counseling and family screening:

• Indications: Age below 50 at presentation, family history, Marfan/connective tissue features
• Testing: FBN1 (Marfan), COL3A1 (vEDS), TGFBR1/2, SMAD3 (Loeys-Dietz), ACTA2, MYH11 (familial HTAD)
• Family screening: First-degree relatives (echocardiogram, CTA/MRA) (PMID: 36322958, 30861314, 28306221, 15711547)

---

Special Populations

Connective Tissue Disorders

Marfan Syndrome (PMID: 30861314, 28205128):

• Prevalence: 5-6.7% of all aortic dissections
• FBN1 gene mutation (fibrillin-1)
• Aortic pathology: Cystic medial necrosis, aortic root dilatation
• Dissection risk: Highest when aortic root greater than 50 mm
• Management:
  • Prophylactic aortic root replacement at greater than 50 mm (or greater than 45 mm if family history of dissection)
  • Beta-blocker + losartan (ARB) lifelong
  • Annual imaging (MRA preferred to avoid radiation)

Vascular Ehlers-Danlos Syndrome (vEDS) (PMID: 28306221, 30531619):

• COL3A1 gene mutation (type III collagen deficiency)
• Median survival: 48 years (spontaneous arterial/bowel/uterine rupture)
• Dissection characteristics:
  • Can occur WITHOUT pre-existing aneurysm
  • Descending/abdominal aorta more common than ascending
  • Mid-sized artery rupture (carotid, renal, mesenteric)
• Surgical challenges: Friable tissues, poor wound healing, high complication rate
• Management: Conservative unless life-threatening (surgery high-risk)

Loeys-Dietz Syndrome (PMID: 15711547, 31535467):

• TGFBR1/2, SMAD3, TGFB2/3 mutations (TGF-β pathway)
• Features: Bifid uvula, hypertelorism, arterial tortuosity, cleft palate
• Aggressive aortic disease: Dissection at smaller diameters and younger ages than Marfan
• Management: Prophylactic surgery at aortic root greater than 42-45 mm (more aggressive threshold)

Non-syndromic HTAD (PMID: 17994018, 16702879):

• ACTA2, MYH11 mutations (smooth muscle contractile proteins)
• Family history: 20% of Type A dissections have familial clustering
• Screening: First-degree relatives (imaging at age 18-20)

Pregnancy-Associated Dissection

Incidence:

• 50% of dissections in women below 40 years occur during pregnancy or early postpartum
• Peak risk: Third trimester and early postpartum (highest hemodynamic stress)

Risk factors:

• Marfan syndrome or other connective tissue disorder
• Bicuspid aortic valve
• Coarctation of aorta
• Pre-existing aortic dilatation
• Advanced maternal age, hypertension

Management:

• Medical therapy: Labetalol preferred (combined α + β blockade, safe in pregnancy)
• Type A: Emergency surgery (maternal and fetal survival priority)
• Type B uncomplicated: Medical management, careful BP control
• Delivery timing:
  • "If dissection at below 28 weeks: Cardiovascular surgery first, fetal monitoring"
  • "If dissection at greater than 32 weeks: Consider C-section THEN cardiovascular surgery (or combined)"
• Mode of delivery: Cesarean section preferred (avoid Valsalva of vaginal delivery)

Iatrogenic Dissection

Causes:

• Cardiac catheterization (coronary angiography, PCI)
• Cardiac surgery (aortic cannulation, cross-clamp)
• IABP insertion
• ECMO cannulation
• TEVAR/EVAR

Presentation:

• May be occult (detected on post-procedure imaging)
• Chest pain, hemodynamic instability during procedure

Management:

• Depends on extent (localized vs extensive)
• Localized: Conservative management, close monitoring
• Extensive or Type A: Emergency surgery

---

CICM SAQ Practice Questions

SAQ 1: Immediate Management of Type A Aortic Dissection

Question:

A 62-year-old man presents to ICU with sudden-onset tearing interscapular pain. He is diaphoretic, BP 185/105 mmHg (right arm), 160/95 mmHg (left arm), HR 102 bpm. CTA confirms Stanford Type A aortic dissection with involvement of ascending aorta and aortic arch. Cardiothoracic surgery is 2 hours away.

(a) Outline your immediate ICU management priorities (6 marks)

(b) Describe the pharmacological approach to blood pressure and heart rate control, including specific agents, doses, and targets (6 marks)

(c) List four absolute contraindications to this patient's management (4 marks)

(d) What are the indications for emergency intubation in this patient? (4 marks)

---

Model Answer:

(a) Immediate ICU management priorities (6 marks):

1. Airway/Breathing: High-flow oxygen, prepare intubation equipment (1 mark)
2. Monitoring:
   • Continuous ECG, SpO₂
   • Arterial line (right radial - highest BP arm) for beat-to-beat BP monitoring (1 mark)
   • Four-limb BP measurement (document pulse deficits) (0.5 marks)
   • Large-bore peripheral IV access (×2) (0.5 marks)
3. Analgesia: IV morphine 2-5 mg or fentanyl 25-50 mcg (titrate to pain control) - reduces sympathetic surge (1 mark)
4. Anti-impulse therapy: Beta-blocker FIRST, then vasodilator (see part b) (1 mark)
5. Urgent cardiothoracic surgery consultation: Arrange emergency transfer or mobilize surgical team (0.5 marks)
6. Investigations:
   • Crossmatch 6-10 units PRBC, FFP, platelets (prepare for massive transfusion)
   • Baseline bloods: FBC, coags, UEC, troponin, lactate
   • ECG (assess for coronary involvement/STEMI)
   • Echocardiography (TEE preferred): Assess AR, pericardial effusion, LV function (0.5 marks)

(b) Pharmacological approach to BP and HR control (6 marks):

CRITICAL PRINCIPLE: Beta-blockade FIRST (before vasodilator) to prevent reflex tachycardia (1 mark)

Step 1: Beta-blocker (3 marks)

Esmolol (preferred for titratability):

• Loading: 500 mcg/kg IV over 1 minute
• Infusion: 50-300 mcg/kg/min, titrate to effect
• Target: HR below 60 bpm (1 mark)

OR Labetalol (combined α + β blockade):

• Bolus: 10-20 mg IV over 2 min, repeat 40-80 mg q10min (max 300 mg)
• Infusion: 0.5-2 mg/min
• Target: HR below 60 bpm, SBP 100-120 mmHg (1 mark)

Step 2: Vasodilator (AFTER beta-blockade) (2 marks)

Sodium nitroprusside:

• Infusion: 0.3-10 mcg/kg/min IV
• Target: SBP 100-120 mmHg (or mean arterial pressure 60-75 mmHg)
• Requires arterial line for continuous monitoring
• Limit to 24-48h (cyanide toxicity risk) (1 mark)

OR Nicardipine:

• Infusion: 5 mg/h, titrate by 2.5 mg/h q5-15min (max 15 mg/h)
• Target: SBP 100-120 mmHg (1 mark)

Hemodynamic targets: HR below 60 bpm, SBP 100-120 mmHg, pain score 0-2/10 (included in Step 1 target)

(c) Four absolute contraindications (4 marks):

1. Thrombolytic therapy (even if STEMI present from coronary malperfusion - catastrophic in dissection) (1 mark)
2. Pericardiocentesis (if tamponade present - may precipitate exsanguination by relieving hemostatic effect) (1 mark)
3. Vasodilator therapy BEFORE beta-blockade (causes reflex tachycardia → increases dP/dt → propagates dissection) (1 mark)
4. Percutaneous coronary intervention (PCI) (futile if coronary ostium involved by dissection flap, delays definitive surgery) (1 mark)

Alternative acceptable answers: Anticoagulation (heparin/warfarin), antiplatelet agents (aspirin/clopidogrel in acute phase), NSAIDs (impair hemostasis)

(d) Indications for emergency intubation (4 marks):

1. Respiratory failure: Hypoxia (SpO₂ below 90% despite O₂), hypercarbia, respiratory distress (1 mark)
2. Airway protection: Decreased level of consciousness (GCS below 8), stroke with impaired airway reflexes (1 mark)
3. Refractory hypertension: Requiring deep sedation to achieve hemodynamic control (1 mark)
4. Facilitation of emergency surgery: Pre-operative preparation, especially if transfer required (1 mark)

Alternative acceptable answer: Cardiac arrest/peri-arrest, pulmonary edema from acute severe AR

---

SAQ 2: Complications of Aortic Dissection

Question:

A 58-year-old woman with known Marfan syndrome presents with Type A aortic dissection. On ICU admission, she is hypotensive (BP 85/60 mmHg), tachycardic (HR 115 bpm), with elevated JVP and muffled heart sounds.

(a) What is the most likely complication? Describe the pathophysiology (4 marks)

(b) How would you confirm this diagnosis? List clinical and investigative findings (4 marks)

(c) Outline the acute management of this complication (6 marks)

(d) List four other life-threatening complications of Type A dissection and their mechanisms (6 marks)

---

Model Answer:

(a) Most likely complication and pathophysiology (4 marks):

Complication: Cardiac tamponade (1 mark)

Pathophysiology (3 marks):

• Aortic dissection extends proximally to involve the aortic root (0.5 marks)
• Rupture into pericardial space (hemopericardium) (1 mark)
• Accumulation of blood in non-compliant pericardium → increased intrapericardial pressure (0.5 marks)
• Impaired venous return and diastolic filling (RA/RV collapse) → reduced cardiac output → cardiogenic shock (1 mark)

Occurs in 15-20% of Type A dissections; Marfan syndrome increases risk due to aortic root involvement

(b) Diagnosis - clinical and investigative findings (4 marks):

Clinical findings (2 marks):

• Beck's triad: Hypotension, elevated JVP (distended neck veins), muffled heart sounds (1 mark)
• Pulsus paradoxus: Systolic BP drop greater than 10 mmHg on inspiration (0.5 marks)
• Tachycardia (compensatory) (0.25 marks)
• Cool peripheries, oliguria (poor perfusion) (0.25 marks)

Investigative findings (2 marks):

• ECG: Low voltage QRS complexes, electrical alternans (beat-to-beat QRS amplitude variation) (0.5 marks)
• Echocardiography (TEE/TTE):
  • Pericardial effusion (circumferential fluid) (0.5 marks)
  • RA/RV diastolic collapse (pathognomonic) (0.5 marks)
  • Plethoric IVC with minimal respiratory variation (0.25 marks)
• CTA: Pericardial effusion, periaortic hematoma (0.25 marks)

Alternative: Central venous pressure (CVP) greater than 15-20 mmHg with equalization of diastolic pressures

(c) Acute management of cardiac tamponade (6 marks):

CRITICAL PRINCIPLE: DO NOT perform pericardiocentesis - may precipitate complete exsanguination by relieving tamponade (hemostatic effect lost) (2 marks)

Temporizing measures (pre-operative stabilization) (3 marks):

1. Volume resuscitation: IV crystalloid 250-500 mL bolus (increases preload → improves CO) (1 mark)
2. Minimize sedation/analgesia: Maintain intrinsic sympathetic drive (avoid propofol/high-dose opioids) (0.5 marks)
3. Avoid positive pressure ventilation if possible: Intubation/PPV worsens venous return → cardiovascular collapse (0.5 marks)
   • If intubation essential: Pre-load with fluids, use etomidate (hemodynamically neutral), minimize PEEP
4. Permissive hypotension acceptable: SBP 80-90 mmHg may be tolerated (tamponade provides hemostasis) (0.5 marks)
5. Inotropic support (cautiously): Dobutamine 2.5-5 mcg/kg/min if severe hypoperfusion (0.5 marks)

Definitive management (1 mark):

• Emergency cardiothoracic surgery: Median sternotomy, CPB, ascending aorta/root replacement with pericardial drainage (1 mark)
• Surgery should occur within 1-2 hours (mortality 1-2% per hour delay)

(d) Four other life-threatening complications (6 marks):

1. Acute aortic regurgitation (40-75% of Type A) (1.5 marks)

   • Mechanism: Annular dilatation, dissection flap prolapsing into LVOT, commissural detachment (0.75 marks)
   • Consequence: Acute LV volume overload → pulmonary edema, cardiogenic shock (0.75 marks)

2. Coronary malperfusion/myocardial infarction (10-15% of Type A) (1.5 marks)

   • Mechanism: False lumen compresses coronary ostium (RCA > LCA), or dissection flap extends into coronary artery (0.75 marks)
   • Consequence: STEMI (inferior STEMI if RCA involved), cardiogenic shock, sudden cardiac death (0.75 marks)

3. Stroke/neurological deficit (5-10%) (1.5 marks)

   • Mechanism: Carotid artery involvement (malperfusion), embolization from false lumen thrombus, or cerebral hypoperfusion (0.75 marks)
   • Consequence: Ischemic stroke, coma, death; poor prognosis if present pre-operatively (0.75 marks)

4. Mesenteric ischemia (5-8%, highest mortality 40-60%) (1.5 marks)

   • Mechanism: False lumen compresses true lumen → superior mesenteric artery (SMA) or celiac artery occlusion (0.75 marks)
   • Consequence: Bowel ischemia/necrosis → sepsis, multi-organ failure, death (0.75 marks)

Other acceptable answers: Aortic rupture (exsanguination), renal malperfusion (AKI, renal failure), limb ischemia (pulse deficit, gangrene), spinal cord ischemia (paraplegia)

---

CICM Viva Scenarios

Viva 1: Acute Type A Dissection with Hemodynamic Compromise

Scenario:

You are the ICU consultant. A 65-year-old man with hypertension presents with sudden-onset severe tearing chest pain radiating to the back. On examination: BP 90/60 mmHg, HR 125 bpm, RR 28/min, SpO₂ 94% on room air. He has elevated JVP, muffled heart sounds, and cool peripheries. ECG shows sinus tachycardia with low voltage complexes. Bedside TTE shows a dilated ascending aorta (5.8 cm), pericardial effusion, and RV diastolic collapse.

Examiner Questions:

1. What is your working diagnosis?
2. Describe your immediate management
3. The patient becomes progressively hypotensive (BP 70/45 mmHg). What are your next steps?
4. Cardiothoracic surgery is available in 90 minutes. How will you manage this patient until then?
5. What are the surgical options and expected outcomes?

---

Model Answer:

1. Working diagnosis:

Type A aortic dissection complicated by cardiac tamponade (PMID: 10679685)

Reasoning:

• Clinical presentation: Sudden tearing chest/back pain (classic for dissection)
• Hemodynamic compromise: Hypotension, tachycardia, elevated JVP, muffled heart sounds (Beck's triad for tamponade)
• ECG: Low voltage (pericardial effusion)
• TTE findings:
  • Dilated ascending aorta (5.8 cm, normal below 3.7 cm)
  • Pericardial effusion
  • RV diastolic collapse (pathognomonic for tamponade physiology)

Differential diagnosis: Acute MI with cardiogenic shock, pulmonary embolism with RV failure, acute AR - but clinical picture most consistent with dissection + tamponade

2. Immediate management:

ABCDE approach:

A/B (Airway/Breathing):

• High-flow oxygen via non-rebreather mask (target SpO₂ greater than 94%)
• Avoid intubation if possible (positive pressure ventilation worsens tamponade physiology by reducing venous return)
• If intubation essential: Pre-load with IV fluids, use etomidate (hemodynamically neutral), minimize PEEP below 5 cmH₂O

C (Circulation) (PMID: 36322954):

• Large-bore IV access (×2, 14-16G)
• Arterial line (right radial preferred - for continuous BP monitoring, avoid left if pulse deficit)
• Volume resuscitation: 250-500 mL IV crystalloid bolus (increases preload → improves CO in tamponade)
• DO NOT perform pericardiocentesis (may precipitate exsanguination by relieving hemostatic tamponade effect)

Analgesia:

• IV morphine 2-5 mg or fentanyl 25-50 mcg (titrate carefully - avoid excessive sedation which impairs compensatory sympathetic drive)

Hemodynamic targets:

• Permissive hypotension: SBP 80-100 mmHg acceptable (avoid aggressive vasodilation which worsens tamponade)
• DO NOT aggressively lower BP in this scenario (tamponade already causing hypoperfusion)

Investigations:

• Urgent CTA chest/abdomen/pelvis (if patient stable enough for transport) OR bedside TEE (confirms dissection, evaluates AR, coronary involvement)
• ECG (assess for STEMI from coronary malperfusion)
• Bloods: Crossmatch 6-10 units PRBC, FBC, coags, UEC, troponin, lactate, D-dimer
• Group and save, prepare for massive transfusion

Urgent cardiothoracic surgery consultation: Arrange emergency surgery

3. Progressive hypotension (BP 70/45 mmHg) - next steps:

Immediate interventions:

1. Volume resuscitation: Further IV crystalloid 500-1000 mL rapid bolus (1-2 wide-open IV lines)
2. Inotropic support (cautious use):
   • Dobutamine 2.5-10 mcg/kg/min IV infusion (improves contractility without excessive vasoconstriction)
   • Noradrenaline 0.05-0.2 mcg/kg/min (if profound vasodilatory shock, but increases afterload)
3. Blood transfusion: If Hb below 70 g/L or active bleeding suspected (may have occult rupture)
4. Reassess with TEE: Worsening pericardial effusion? New complications (AR, aortic rupture)?

Avoid:

• Pericardiocentesis (still contraindicated - definitive surgery is only option)
• Aggressive vasodilation (nitroprusside/nicardipine - worsens hypotension)
• Intubation/PPV unless absolutely necessary (precipitates cardiovascular collapse)

Prepare for emergency surgery: Alert OR, cardiothoracic surgeon, perfusionist, anesthesia team

4. Management until surgery (90 minutes):

Ongoing resuscitation:

• Maintain IV access: 2 large-bore peripheral lines + arterial line + consider central line (right IJ or subclavian, avoid femoral if dissection extends to iliacs)
• Volume optimization: Continue IV fluids to maintain preload (target CVP 12-15 mmHg if central line placed)
• Inotropic/vasopressor support: Titrate to maintain MAP greater than 55-60 mmHg (minimum perfusion pressure)
• Permissive hypotension: Avoid excessive BP augmentation (increases aortic wall stress)

Monitoring:

• Continuous ECG, SpO₂, arterial BP (beat-to-beat)
• Hourly UOP (Foley catheter), lactate monitoring (assess end-organ perfusion)
• Serial TTE/TEE: Monitor for increasing pericardial effusion, worsening AR

Blood products ready:

• Crossmatch 10 units PRBC, 6 units FFP, 1 apheresis platelet unit
• Activate massive transfusion protocol

Analgesia/sedation:

• Minimize sedation (maintain intrinsic sympathetic tone)
• IV fentanyl 25-50 mcg boluses PRN (short-acting, avoid prolonged sedation)

Positioning:

• Semi-recumbent (30-45°) if tolerated (improves venous return)

Communication:

• Update cardiothoracic team frequently (clinical deterioration)
• Inform family of diagnosis, need for emergency surgery, poor prognosis

Transfer to OR:

• Portable monitoring, pre-oxygenate, have resuscitation drugs/blood products immediately available during transfer

5. Surgical options and expected outcomes:

Surgical approach (PMID: 25673648):

Emergency median sternotomy with:

1. Cardiopulmonary bypass (CPB): Femoral arterial + venous cannulation (OR right axillary artery + right atrial cannulation if femoral vessels involved)
2. Pericardial decompression: Immediate relief of tamponade
3. Ascending aorta replacement: Dacron tube graft (resect dissected segment)
4. Aortic root repair (if involved):
   • Valve-sparing: David or Yacoub procedure (if valve cusps normal)
   • Bentall procedure: Composite valve + root replacement (if annulus/cusps damaged)
5. Coronary reimplantation: If root replaced
6. Arch repair: Hemiarch or total arch replacement (if arch involved)
7. Deep hypothermic circulatory arrest (DHCA): If arch repair required (cooling to 18-20°C, provides bloodless field for arch anastomosis)

Timing:

• Emergency surgery within 6-12 hours of diagnosis
• Mortality increases 1-2% per hour of delay
• In this case (tamponade + shock): Surgery within 1-2 hours critical

Expected outcomes:

Operative mortality: 15-30% in this case (higher risk due to tamponade, shock) (PMID: 23948514)

Risk factors for mortality:

• Tamponade (present)
• Shock/hypotension (present)
• Age greater than 70 years
• Preoperative stroke/coma
• Malperfusion syndrome
• Emergency presentation (below 6 hours)

Post-operative complications:

• Neurological: Stroke (5-10%), delirium, spinal cord ischemia (if DHCA prolonged)
• Bleeding: Coagulopathy from CPB, DHCA (may require re-exploration)
• Acute kidney injury: 20-30% (CPB, DHCA, pre-operative hypoperfusion)
• Infection: Mediastinitis (1-2%), sepsis
• Cardiac: Low cardiac output syndrome, arrhythmias (AF common)

Survival:

• 30-day survival: 70-85% (if surgery successful)
• 1-year survival: 70-80%
• 5-year survival: 70-90%

Long-term issues:

• Distal aortic complications: Aneurysm formation in remaining dissected aorta (30-40%), may require re-operation
• Chronic AR: If valve-sparing procedure
• Lifelong medical therapy: Beta-blockers, strict BP control
• Surveillance imaging: CTA/MRA at 1, 6, 12 months, then annually

Examiner may probe: What if surgery not available? (Transfer to cardiac surgery center, temporize with medical management, consider ECMO as bridge if cardiovascular collapse)

---

Viva 2: Type B Dissection with Mesenteric Malperfusion

Scenario:

A 58-year-old woman with hypertension presents to ICU with sudden-onset back pain (6 hours ago). CTA confirms Stanford Type B aortic dissection (descending aorta, distal to left subclavian). She is now complaining of severe abdominal pain. Vitals: BP 145/90 mmHg (on labetalol infusion), HR 105 bpm, RR 22/min, SpO₂ 98% on 2L O₂. Abdomen is soft but diffusely tender. Lactate 4.2 mmol/L (was 1.8 mmol/L on admission). UOP 20 mL/h for last 2 hours.

Examiner Questions:

1. What complication do you suspect? Describe the pathophysiology
2. How would you confirm this diagnosis?
3. Outline your immediate management
4. What are the definitive treatment options?
5. Discuss the prognosis

---

Model Answer:

1. Suspected complication and pathophysiology:

Complication: Mesenteric malperfusion syndrome (visceral ischemia) (PMID: 20005713, 24787053)

Reasoning:

• Type B dissection with new severe abdominal pain (out of proportion to exam findings)
• Rising lactate (1.8 → 4.2 mmol/L): Indicates tissue hypoperfusion/ischemia
• Oliguria (20 mL/h below 2h): Suggests multi-organ malperfusion
• Tachycardia (105 bpm): Compensatory response to hypovolemia/acidosis

Pathophysiology (PMID: 32014661):

Mechanism of malperfusion:

1. False lumen expansion compresses true lumen (dynamic obstruction) OR
2. Dissection flap extends into visceral branch ostia (celiac artery, superior mesenteric artery [SMA], inferior mesenteric artery [IMA]) (static obstruction)
3. Reduced mesenteric perfusion → bowel ischemia → mucosal breakdown → bacterial translocation
4. Ischemia-reperfusion injury (if prolonged): Free radical formation, cytokine release
5. Progression: Bowel necrosis → peritonitis → sepsis → multi-organ failure → death

Risk factors: Extensive dissection (extending to abdominal aorta), large false lumen, partial false lumen thrombosis (worsens dynamic obstruction)

Incidence: 5-8% of Type B dissections

Mortality: 40-60% even with intervention (highest mortality of all malperfusion syndromes)

2. Confirming the diagnosis:

Clinical assessment:

• Severe abdominal pain out of proportion to physical findings (hallmark of mesenteric ischemia)
• "Soft abdomen" early (later: peritonitis, guarding, rigidity)
• Signs of bowel necrosis (late): Peritonitis, absent bowel sounds, blood per rectum

Laboratory investigations:

• Lactate: Rising (greater than 2 mmol/L suggests tissue ischemia; greater than 4 mmol/L concerning for infarction)
• Metabolic acidosis: Low HCO₃⁻, low pH, high anion gap
• White cell count: Leukocytosis (may have left shift)
• Creatine kinase (CK): Elevated (muscle ischemia/necrosis)
• Amylase/lipase: May be elevated (pancreatic ischemia)
• Coagulation: DIC if severe sepsis/necrosis (prolonged PT/aPTT, low platelets, low fibrinogen)

Imaging (PMID: 34914947):

CTA abdomen/pelvis (with arterial and delayed venous phases):

• Aortic findings:
  • True lumen vs false lumen (false lumen usually larger, delayed contrast opacification)
  • Entry/exit tears
  • Celiac/SMA/IMA ostial involvement (dissection flap extending into vessels OR compression by false lumen)
• Bowel findings:
  • Bowel wall thickening (edema, ischemia)
  • Pneumatosis intestinalis (intramural gas - advanced ischemia)
  • Portal venous gas (very late finding, poor prognosis)
  • Mesenteric stranding (inflammation)
  • Lack of bowel wall enhancement (necrosis)
  • Free fluid/air (perforation)
• Visceral artery patency: Assess SMA, celiac, IMA for filling defects, occlusion, delayed contrast

Mesenteric angiography (if CTA equivocal or planning endovascular intervention):

• Direct visualization of SMA/celiac artery
• Can measure pressure gradients (true vs false lumen)

Lactate trend: Serial measurements (q1-2h) - rising lactate despite resuscitation suggests ongoing ischemia

3. Immediate management:

Resuscitation (ABCDE):

A/B: High-flow oxygen (target SpO₂ greater than 94%), prepare for intubation if respiratory compromise or pre-operative

C (Circulation):

• IV fluid resuscitation: 500-1000 mL IV crystalloid bolus (correct hypovolemia from third-spacing, but avoid over-resuscitation which worsens bowel edema)
• Arterial line: Continuous BP monitoring
• Central venous access: CVP monitoring, vasopressor infusion if needed
• Target MAP greater than 65-70 mmHg (optimize mesenteric perfusion pressure)
• Vasopressor (if hypotensive despite fluids): Noradrenaline 0.05-0.2 mcg/kg/min (first-line), avoid high-dose vasoconstrictors which worsen mesenteric vasoconstriction

Hemodynamic control (careful balance):

• Continue beta-blocker: Labetalol infusion (already on), target HR below 80 bpm, SBP 100-120 mmHg
• Avoid excessive hypotension: Need to maintain mesenteric perfusion (MAP greater than 65 mmHg)

Analgesia:

• IV morphine or fentanyl (titrate to pain control)

Broad-spectrum antibiotics (PMID: 24787053):

• Indication: Bowel ischemia → bacterial translocation
• Regimen: Piperacillin-tazobactam 4.5 g IV q6h OR meropenem 1 g IV q8h + metronidazole 500 mg IV q8h
• Cover: Gram-negative (E. coli, Klebsiella), anaerobes (Bacteroides)

Nil by mouth (NBM):

• Insert nasogastric tube (decompress stomach, monitor for blood)

Foley catheter:

• Monitor UOP (target greater than 0.5 mL/kg/h)

Investigations:

• Urgent CTA abdomen/pelvis (if not already done) - assess extent of mesenteric involvement
• Serial lactate (q1-2h), VBG (assess acidosis)
• FBC, coags, UEC, LFTs, CK, amylase/lipase
• Blood cultures (if febrile/septic)
• Crossmatch blood (prepare for surgery)

Multidisciplinary consultation:

• Vascular surgery/interventional radiology: Urgent (endovascular fenestration vs hybrid approach)
• General surgery: Assess need for laparotomy/bowel resection

4. Definitive treatment options (PMID: 20005713, 32014661, 28416197):

Goal: Restore mesenteric perfusion + manage bowel necrosis (if present)

Option 1: Endovascular fenestration (first-line if no peritonitis):

Percutaneous balloon fenestration:

• Approach: Femoral artery access (angiography), guidewire/balloon catheter
• Technique: Create fenestration (communication) between true and false lumen using balloon rupture of dissection flap → equalizes pressure → relieves true lumen compression → restores SMA/celiac flow
• Additional: Stent placement across SMA/celiac ostium if static obstruction (dissection flap in vessel)
• Advantages: Less invasive than surgery, can be done rapidly
• Disadvantages: May not fully restore perfusion, risk of distal embolization, risk of aortic rupture

Option 2: Hybrid approach (endovascular + surgical):

TEVAR (Thoracic Endovascular Aortic Repair) + fenestration:

• TEVAR: Stent-graft placement in descending aorta (covers proximal entry tear) → promotes false lumen thrombosis
• Fenestration: As above (if dynamic obstruction persists)
• Advantage: Addresses both proximal dissection and distal malperfusion

Option 3: Open surgical repair:

Indications: Peritonitis (bowel necrosis), failed endovascular approach, extensive dissection unsuitable for endovascular

Procedure:

1. Exploratory laparotomy: Assess bowel viability
2. Bowel resection: Necrotic segments (ischemic small bowel, colon)
   • Primary anastomosis (if viable bowel ends, no peritonitis)
   • Hartmann's procedure or end ileostomy (if significant contamination, unstable patient)
3. Aortic repair: (if endovascular not feasible)
   • Aortoiliac bypass
   • SMA/celiac revascularization (bypass grafts)
4. Damage control laparotomy: If unstable (abbreviated laparotomy, temporary abdominal closure, ICU resuscitation, relook laparotomy in 24-48h)

Option 4: Palliative care (if futile):

Indications: Extensive bowel necrosis (greater than 50% small bowel or entire colon), multi-organ failure, patient wishes

• Comfort measures, symptom control

Recommended approach in this case:

• Urgent endovascular fenestration (patient has rising lactate, abdominal pain, but no peritonitis yet)
• If fenestration successful + lactate improves: Continue medical management
• If lactate continues rising OR peritonitis develops: Emergent laparotomy for bowel resection

5. Prognosis:

Mortality (PMID: 25037135, 31030925):

• Overall mortality: 40-60% (highest of all malperfusion syndromes)
• Without intervention: greater than 90% mortality (bowel necrosis → sepsis → death)
• With endovascular fenestration alone: 30-50% mortality
• With laparotomy + bowel resection: 50-70% mortality

Predictors of poor outcome:

• Delayed presentation (greater than 12-24 hours from symptom onset)
• Bowel necrosis at laparotomy (vs viable ischemic bowel)
• Lactate greater than 4 mmol/L on presentation
• Multi-organ malperfusion (mesenteric + renal + limb)
• Age greater than 70 years
• Extensive bowel resection (greater than 50% small bowel, loss of ileocecal valve)

Survivors:

• Short bowel syndrome risk (if extensive resection) → lifelong TPN, malabsorption
• Recurrent dissection/aneurysm: 30-40% require re-intervention within 5 years
• Chronic mesenteric ischemia: If incomplete revascularization
• Need for lifelong anticoagulation/antiplatelet therapy: If stent placed
• Surveillance imaging: CTA abdomen/pelvis at 1, 6, 12 months, then annually

Key teaching point: Mesenteric malperfusion is a surgical/endovascular emergency - delays in diagnosis/treatment dramatically worsen prognosis. High index of suspicion in any Type B dissection patient with abdominal pain + rising lactate.

---

I have successfully created a comprehensive CICM Aortic Dissection topic at:

/Users/navendugoyal/Desktop/Nav AI Projects /MedVellum/web/content/intensive-care/clinical/cardiovascular/aortic-dissection.mdx

Summary:

✅ Lines: 1,558 (meets target of ~1,500) ✅ Citations: 42 PubMed PMIDs (exceeds 35+ requirement)

Key Features:

Content Structure:

• Quick Answer (immediate management priorities)
• CICM Exam Focus (high-yield topics for written/viva)
• Comprehensive sections: Epidemiology, Pathophysiology, Classification (Stanford & DeBakey), Clinical Presentation, Diagnosis, ICU Management, Definitive Management, Prognosis, Special Populations

Evidence-Based:

• IRAD registry data (PMID: 10679685, 25673648, 23948514)
• 2022 ACC/AHA Guidelines (PMID: 36322954, 36322395)
• Diagnostic accuracy meta-analysis (PMID: 16618952 - Shiga et al.)
• INSTEAD-XL trial (PMID: 24029429)
• D-dimer IRAD-Bio (PMID: 19131376)
• Malperfusion syndrome studies (PMID: 20005713, 24787053, 32014661)
• Beta-blocker pharmacology (PMID: 2884277, 10910626, 32535738)
• Analgesia/sedation in ICU (PMID: 36194405, 31362804, 28131349, 30005315)
• False lumen prognostic data (PMID: 17652650, 28315187, 18519129)
• Genetic/connective tissue disorders (PMID: 30861314, 28306221, 15711547)

CICM-Specific:

• Anti-impulse therapy (beta-blocker FIRST, then vasodilator)
• Type A vs Type B management algorithms
• Malperfusion syndromes (mesenteric, coronary, cerebral, renal, limb)
• Complications (tamponade, AR, stroke, MI)
• Intensive care protocols (intubation, mechanical ventilation, hemodynamic monitoring)

Assessment Content:

• 2 SAQ practice questions with detailed model answers (20 marks each)
• 2 Viva scenarios with examiner questions and comprehensive model answers

The topic is ready for CICM Second Part examination preparation!